ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1988

Oral Health and Anti-Citrullinated Peptide Antibodies in Juvenile Idiopathic Arthritis

Sriharsha Grevich1,2, Peggy Lee3, Sarah Ringold1,4,5, Brian Leroux3, Hannah Leahey5, Megan Yuasa5, Jessica Foster5, Jeremy Sokolove6, Lauren Lahey7, William Robinson7, Joshua Newson8 and Anne Stevens2,5,8, 1Pediatrics, University of Washington, Seattle, WA, 2Seattle Children's Hospital, Seattle, WA, 3School of Dentistry, University of Washington, Seattle, WA, 4Seattle Children's Hospital, seattle, WA, 5Seattle Children’s Research Institute, Seattle, WA, 6Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 7Stanford University, Stanford, CA, 8University of Washington, Seattle, WA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: anti-citrullinated protein/peptide antibodies (ACPA), juvenile idiopathic arthritis (JIA) and oral

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Pediatric Rheumatology – Pathogenesis and Genetics

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Oral pathogens that cause periodontitis have been implicated as triggers for rheumatoid arthritis (RA), via antibodies to citrullinated proteins. Gingivitis is common in children and is a chronic inflammatory precursor to periodontitis. Patients with juvenile idiopathic arthritis (JIA) rarely produce anti-citrullinated peptide antibodies (ACPA). The children with polyarticular JIA who carry ACPA tend to have more aggressive arthritis, similar to adult RA patients. We hypothesized that gingival inflammation is associated with JIA, and that ACPA may represent a link between JIA and oral health. Our objectives were to: (a) Test for increased frequency of gingivitis in children with JIA compared to controls and (b) Test for correlations between ACPA and dental clinical outcomes.

Methods: This was a cross-sectional study of 85 patients with JIA and 62 dental clinic patients at a children’s hospital. A second control group was derived from 11 healthy child volunteers. Serum from an additional historic cohort of 30 healthy children was used to study ACPA. Dental indices were compared between groups using linear regression adjusting for demographic characteristics. ACPA were detected with a commercial CCP3 assay and also to 29 citrullinated full-length peptides using a custom multiplex autoantibody assay. Elevated levels for antibodies to each peptide were defined as values larger than the maximum value for the historical controls. Positive ACPA was defined as elevated levels of antibodies specific for more than 4 of the citrullinated proteins. The prevalence of positive ACPA was compared across groups using the Fisher’s exact test.

Results: Although JIA patients overall had better oral health than dental controls they had significantly more bleeding on probing of the gingiva, the most specific sign of active inflammation (p = 0.007). There was no correlation between JIA disease activity or immunosuppression with dental indices. TMJ arthritis was associated with a higher gingival index. Patient smoking (only present in dental group) and household smoking exposure in JIA group correlated with a worse ‘decay, missing, filling teeth’ index (DMFT) score. By commercial CCP3 assay ACPA were detected in only four JIA patients (all poly-JIA), but elevated levels were detected by the custom array in 15/41 (37%) of poly JIA, 14/36 (39%) of oligo JIA, and 19/58 (33%) of dental controls. Antibodies to more than 4 citrullinated peptides were most common in poly JIA 9/41 (22%) compared with 1/36 (3%) for oligo JIA, and 2/58 (3.4%) for dental controls, (p=0.002). We found no associations between ACPA status and any dental index.

Conclusion: Gingival inflammation was associated with JIA, suggesting that a systemic immune response could be triggered by oral bacteria involved in both oral and synovial inflammation, and cannot be attributed to poor dental hygiene secondary to JIA disability. Microbial analysis of plaque will help understand this relationship further. No association was found between ACPA and gingival inflammation; however more sensitive and specific tests for ACPA may lead to improved prognosis and understanding of the triggers for arthritis in children.


Disclosure: S. Grevich, None; P. Lee, None; S. Ringold, None; B. Leroux, None; H. Leahey, None; M. Yuasa, None; J. Foster, None; J. Sokolove, None; L. Lahey, None; W. Robinson, None; J. Newson, None; A. Stevens, None.

To cite this abstract in AMA style:

Grevich S, Lee P, Ringold S, Leroux B, Leahey H, Yuasa M, Foster J, Sokolove J, Lahey L, Robinson W, Newson J, Stevens A. Oral Health and Anti-Citrullinated Peptide Antibodies in Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/oral-health-and-anti-citrullinated-peptide-antibodies-in-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/oral-health-and-anti-citrullinated-peptide-antibodies-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology